Search for a command to run...
Introduction. Bringing medicines for medical use to the market is an extremely expensive and resource-intensive process associated with long-term development, high risks, quality assurance of the final product, safety and efficiency, while limited by strict regulatory requirements. The key goals of the pharmaceutical industry development are to promote the conditions for guaranteeing the safety of the Russian Federation in the field of drug provision to the population and drug availability in all segments, ensuring an advanced level of scientific, technical and technological development of the pharmaceutical industry, creating an export-oriented potential, the presence of competencies in research and development, full-cycle production, implementation in clinical practice and export of medicines. The development of the pharmaceutical and medical industry of the Russian Federation involves not only a consistently pursued import substitution policy, but also the task of realizing the export potential to ensure comprehensive support for the stability of the national pharmaceutical market. Text. The article demonstrates data on the export of Russian medicines, suggests possible methods and tools for reducing barriers to entering foreign markets and supporting the export activities of domestic manufacturers. Conclusion. The main areas of implementation of the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation until 2030 provide for support for the export of Russian pharmaceutical products. The application of the system for assessing the levels of readiness of export potential will allow it to be used as a tool for reducing barriers to entry into foreign markets and strengthening the positions of Russian manufacturers, including ensuring harmonization of regulation with the best international practices.
Published in: Drug development & registration
Volume 14, Issue 4, pp. 307-317